Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.

We have estimated the pharmacokinetic and pharmacodynamic interactions of verapamil (VP) enantiomers and also the interaction between VP and its metabolite, norverapamil (NVP). ECGs of conscious rabbits were studied to determine the pharmacokinetics of VP enantiomers and racemic NVP in relation to their prolongation effect on PR intervals, which were used as an index of VP's antiarrhythmic effect. Plasma free fractions of VP enantiomers showed constant values at concentrations ranging from 0.022 to 1.10 microm. There were no interactions between enantiomers or between VP and NVP. The pharmacological effect of the S-enantiomer (S-VP), which was determined by linear regression analysis, showed it was about 20 times more potent than that of the R-enantiomer (R-VP). The effect of racemic VP was the simple sum of those elicited by both enantiomers. These relationships were not significantly different between intravenous infusion and bolus injection. Simultaneous intravenous infusion of NVP had no influence on the PR intervals. In conclusion, we demonstrated that the relationship between plasma unbound concentration of VP enantiomers and their pharmacological effect was the simple sum of two enantiomers.

[1]  K. Hanada,et al.  Enantioselective Binding of Propranolol, Disopyramide, and Verapamil to Human α1‐Acid Glycoprotein , 2000 .

[2]  K. Hanada,et al.  Quantitative determination of disopyramide, verapamil and flecainide enantiomers in rat plasma and tissues by high-performance liquid chromatography. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[3]  A. Urae,et al.  No Effect of High‐Protein Food on the Stereoselective Bioavailability and Pharmacokinetics of Verapamil , 1996, Journal of clinical pharmacology.

[4]  T. Nakagawa,et al.  Capillary electrophoresis/frontal analysis for microanalysis of enantioselective protein binding of a basic drug. , 1995, Analytical chemistry.

[5]  H. Ogata,et al.  Dosing rate-dependent relationship between propranolol plasma concentration and beta-blockade. , 1993, The Journal of pharmacology and experimental therapeutics.

[6]  M. Eichelbaum,et al.  Stereoselective protein binding of verapamil enantiomers. , 1988, Biochemical pharmacology.

[7]  M. Eichelbaum,et al.  Electrophysiologic Effects of Dextro‐ and Levo‐Verapamil on Sinus Node and AV Node Function in Humans , 1988, Journal of cardiovascular pharmacology.

[8]  M. Eichelbaum,et al.  Effects of d,l‐verapamil on atrioventricular conduction in relation to its stereoselective first‐pass metabolism , 1985, Clinical pharmacology and therapeutics.

[9]  W. L. Nelson,et al.  The Pharmacokinetics and Pharmacodynamics of d- and dl-Verapamil in Rabbits , 1985, Journal of cardiovascular pharmacology.

[10]  M. Eichelbaum,et al.  The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans. , 1985, American heart journal.

[11]  M. Eichelbaum,et al.  Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. , 1984, British journal of clinical pharmacology.

[12]  G. Neugebauer.  Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog. , 1978, Cardiovascular research.